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Abstract
Introduction We recently demonstrated that intravenously
infused recombinant human activated protein C (APC)
attenuates ovine lipopolysaccharide (LPS)-induced lung injury.
In this study, our aim was to find out whether treatment with
inhaled aerosolised APC (inhAPC) prevents formation of
increased lung densities and oedema and derangement of
oxygenation during exposure to LPS.
Methods Sheep were anaesthetised during placement of
intravascular introducers. After one to four days of recovery from
instrumentation, the animals were re-anaesthetised,
endotracheally intubated and mechanically ventilated
throughout a six-hour experiment where the sheep underwent
quantitative lung computed tomography. Sheep were randomly
assigned to one of three groups: a sham-operated group (n = 8)
receiving inhaled aerosolised saline from two hours after the
start of the experiment; a LPS group (n = 8) receiving an
intravenous infusion of LPS 20 ng/kg per hour and, after two
hours, inhaled aerosolised saline over the next four hours; a
LPS+inhAPC group (n = 8) receiving an intravenous infusion of
LPS 20 ng/kg per hour and, after two hours, aerosolised APC
48 g/kg per hour inhaled throughout the experiment. Data were
analysed with analysis of variance; P  less than 0.05 was
regarded as significant.
Results An infusion of LPS was associated with a reduction of
well-aerated lung volume and a rapid fall in arterial oxygenation
that were both significantly antagonised by inhaled APC.
Pulmonary vascular pressures and extravascular lung water
index increased significantly during exposure to LPS, but inhaled
APC had no effect on these changes.
Conclusions Inhalation of aerosolised APC attenuates LPS-
induced lung injury in sheep by preventing a decline in the
volume of aerated lung tissue and improving oxygenation.
Introduction
Acute lung injury (ALI) often accompanying sepsis as the first
organ failure [1]. When exposed to microbial lipopolysaccha-
ride (LPS), the vasculature responds by activating both the
coagulation and inflammation systems. Products released
from these systems act on the lung's circulation and its small
airways, resulting in vasoconstriction and bronchoconstriction,
neutrophil infiltration, vascular leaks, depletion of surfactant,
generation of hyaline membranes and closure of small airways
[2,3].
AaPO2: alveolar-arterial oxygen tension difference; ALI: acute lung injury; APC: activated protein C; ARDS: acute respiratory distress syndrome; CI: 
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Enhanced extravascular lung water (EVLW) content and dete-
riorated oxygenation are clinical hallmarks of ALI [4]. Recently,
investigators noticed a close correlation between lung
oedema, determined by thermal dye dilution, and changes in
lung volumes, determined with quantitative tomography in
patients with acute respiratory distress syndrome (ARDS) [5].
In mechanically ventilated sheep subjected to saline washout-
induced lung injury, researchers noticed an increase in
extravascular lung water, which was antagonised by positive
end-expiratory pressure (PEEP) [6]. The decrease in EVLW
also correlated closely with the PEEP-induced fall in non-aer-
ated lung volume and the decline in the transpulmonary shunt
[7]. Thus, both EVLW and lung computed tomography (CT)
might be useful tools for the assessment of changes in ALI
subsequent to therapeutic interventions.
Activated protein C (APC) counteracts coagulation, promotes
fibrinolysis [8] and inhibits leucocyte infiltration and, subse-
quently, the release of pro-inflammatory cytokines [9,10]. We
recently reported that intravenously administered recombinant
human APC attenuates LPS-induced and oleic acid-induced
lung injury in sheep by reducing lung oedema and improving
oxygenation [11,12]. Here, we hypothesise that APC reduces
LPS-induced lung injury after it is nebulised and inhaled as an
aerosol. Thus, our aim was to find out if inhaled APC preserves
aeration of lung volumes, as assessed by quantitative CT, pre-
vents the appearance of lung oedema and the derangement of
oxygenation in an ovine model of LPS-induced lung injury.
Materials and methods
The experiment was approved by the Norwegian Experimental
Animal Board and performed in accordance with the Helsinki
Convention for Use and Care of Animals.
Sheep were instrumented under sterile conditions during gen-
eral anaesthesia induced with thiopental sodium (Abbott,
North Chicago, IL, USA) 15 to 20 mg/kg intravenously for
endotracheal intubation and maintained with isoflurane 1.2 to
1.5% (Abbott Scandinavia AB, Kista, Sweden). An 8.5 Fr
introducer (CC-350B; Baxter, Irvine, CA, USA) was inserted
transcutaneously into the left external jugular vein and a 5 Fr
introducer was inserted into the ipsilateral carotid artery (CP-
07511-P; Arrow international, Reading, PA, USA). Postopera-
tively, sheep were allowed to recover from instrumentation for
one to four days with free access to food and water while
receiving buphrenorphine (Temgesic, Schering-Plough Cor-
poration, Kenilworth, NJ, USA) 0.6 mg subcutaneously twice
daily. Antibiotic prophylaxis was performed with enrofloxacin
(Bayer Health Care, Monheim, Germany). Introducers and
catheters were flushed twice daily with heparin (Heparin, LEO
Pharma AS, Ballerup, Denmark) 5 mIU dissolved in 5 mL of
saline.
On the day of the experiment, the sheep were anaesthetised
with thiopental dosed as above for endotracheal intubation,
and subsequently sedated with fentanyl (Leptanal; Janssen
Pharmaceuticals, Beerse, Belgium) 0.05 mg/kg per hour and
midazolam (Dormicum; Roche, Basel, Switzerland) 1 mg/kg
per hour. Additional intravenous bolus doses of fentanyl and
midazolam were administered intermittently as necessary with
no use of muscle relaxants. Positive pressure ventilation was
employed using a Servo 900 C respirator (Siemens-Elema,
Solna, Sweden) with tidal volume set at a constant 6 ml/kg,
fraction of inspired oxygen (FiO2) of 0.21, respiratory rate of
20 breaths/minute and zero PEEP. A Swan Ganz catheter
(131HF7; Baxter Healthcare, Irvine, CA, USA) was inserted
into the pulmonary artery via the introducer in the external jug-
ular vein, and a thermodilution catheter (PV2014L16; Pulsion
Medical Systems, Munich, Germany) was inserted into the
aorta through the introducer in the carotid artery.
Experimental protocol
Sheep were randomly assigned to either a sham-operated
group (Sham group, n = 8) or one of two LPS groups receiving
an intravenous infusion of Eschericia coli lipopolysaccharide
O26:B6 (Sigma Chemical, St. Louis, MO, USA) 20 ng/kg per
minute for six hours. One group received LPS only (LPS
group, n = 8) and one group additionally received APC
(Xigris®, Eli Lilly & Co, Indianapolis, IN, USA) 48 g/kg per
hour, which was dissolved in 5 mL of isotonic saline, nebulised
with an ultrasound nebuliser (Servo Ultra 145, Siemens-
Elema, Solna, Sweden) and inhaled as an aerosol from two to
six hours after the start of LPS treatment (LPS+inhAPC-group,
n = 8). Correspondingly, the Sham and the LPS groups
inhaled 5 mL per hour of aerosolised solvent. Aerosolised APC
or solvent was administered in the inspiratory arm of the
breathing system. Sheep in the Sham and LPS groups
received 3 and 5 mL/kg per hour, respectively, of a continuous
intravenous infusion of Ringer's acetate.
Blood samples were drawn from the systemic (a) and pulmo-
nary artery (v) lines every second hour and analysed for blood
gases and haemoglobin (Rapid 860; Chiron Diagnostics Cor-
poration, East Walpole, MA, USA). Body temperature (Temp)
was taken from the thermodilution catheter in the aorta.
Venous admixture (Qs/Qt) and alveolo-arterial oxygen tension
difference (AaPO2) were determined according to standard
formulas.
Haemodynamics were monitored every second hour employ-
ing a Swan Ganz-catheter in the pulmonary artery and a ther-
modilution catheter in the aorta connected to the PiCCO plus
monitor (PiCCO plus; Pulsion Medical Systems, Munich, Ger-
many). The single transpulmonary thermodilution technique
was used to determine the cardiac index (CI) and derived vol-
umetric data. The recorded variables included pulmonary
artery pressure (PAP), pulmonary arterial occlusion pressure
(PAOP), pulmonary micro-occlusion pressure (Pmo), pulmo-
nary vascular resistance index (PVRI), heart rate (HR), CI, sys-
temic arterial blood pressure (MAP), systemic vascularAvailable online http://ccforum.com/content/13/2/R51
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resistance index (SVRI), right atrial pressure (RAP), left ven-
tricular stroke work index (LVSWI), right ventricular stroke
work index (RVSWI) and extravascular lung water index
(EVLWI). Derived volumetric variables were calculated as
described previously by our group [13].
After six hours, a spiral lung CT (Somatom sensation 16) with
slice thickness (voxels) of 5 mm was carried out, while clamp-
ing the tube for 15 seconds at functional residual capacity
(FRC) and at end-inspiration, respectively. Delineation of the
lung contour with exclusion of vessels and bronchi was manu-
ally performed by a radiologist blinded to which group the
sheep belonged to. Acquisition and analysis of CT data was
performed using the Pulmo CT program (Siemens, Munich,
Germany). Density of the lungs was determined in Houndsfield
Units (HU). A CT-number equal to 0 HU characterises a voxel
whose density is equal to that of water and a CT number of -
1000 HU characterises a voxel whose density is equal to that
of air.
The CT number is linearly correlated with density [14], so
quantitative analysis of weight and gas content of lung tissue
could be performed [15]. Regions of pre-defined densities
were identified, and their volumes were calculated automati-
cally by the program. Volumes containing lung densities rang-
ing from -1000 to -500 HU were defined as 'well aerated' lung,
and correspondingly, 'poorly aerated' lung volumes ranged
from -500 to -100 HU and 'non-aerated' lung volumes ranged
from -100 to +100 HU. Tissue volume index was calculated
according to the formula:
where TVICT = CT-derived relative lung tissue volume index
(mL/kg); VWA = volume of well aerated lung (mL/kg); VPA = vol-
ume of poorly aerated lung (mL/kg); VNA = volume of non-aer-
ated lung (mL/kg).
The volume of gas in each lung was calculated as:
The animals were euthanased with an intravenous injection of
pentobarbital (Pentobarbital NAF, Ås Production Lab, Ås, Nor-
way) 100 mg/kg followed by a bolus injection of potassium
chloride (KCl NAF, Ås Production Lab, Ås, Norway) 300 mmol.
Statistical analysis
Data were analysed using a two-factor analysis of variance for
repeated measurements (SPSS 14.0 for Windows, LEAD
Technologies, Chicago, IL, USA) and expressed as mean ±
standard error of the mean (SEM). To evaluate differences
within groups over time and interaction between time and
group, we employed a test of contrasts. Greenhouse-Geisser
epsilon factor adjusted probability levels were used when
Mauchly's test was significant. To test for differences in aera-
tion estimated by CT we applied Student's t-test or Mann-
Whitney U-test when appropriate. We regarded P less than
0.05 as statistically significant.
Results
All sheep survived the experiments. There were no significant
differences between the groups at baseline. As shown in Fig-
ure 1, infusion of LPS rapidly deteriorated oxygenation as evi-
denced by a decrease in partial pressure of oxygen in arterial
blood (PaO2; P < 0.001) in parallel with rises in AaPO2 and
Qs/Qt (P < 0.001 for both variables). InhAPC antagonised the
decline in oxygenation with significant intergroup differences
in PaO2 (P = 0.009), AaPO2 (P = 0.002) and Qs/Qt (P =
0.025). Table 1 displays that oxygen saturation (SaO2) and
mixed venous oxygen saturation (SvO2) both improved signifi-
cantly on inhalation of APC, but without significant intergroup
differences compared with LPS alone. Blood temperature
increased in all groups, including sham-operated sheep (P =
0.02). The latter group did not reach the levels of animals
exposed to LPS alone (P < 0.001). An early increase in hae-
moglobin concentration was observed in both LPS groups (P
< 0.001). Inhaled APC displayed no significant effects on the
changes in haemoglobin or blood temperature. Except for a
slight increase in pH (P = 0.002) and a decrease in partial
pressure of carbon dioxide in arterial blood (PaCO2;  P  =
0.013) after inhaled APC, we noticed no changes in acid-base
balance.
Figure 2 shows representative CT scans taken at FRC of an
animal from the sham group (top), one from the LPS (middle)
group and one from the LPS+inhAPC (bottom) group. As
depicted in Figure 3, at FRC the LPS+inhAPC group pre-
sented with a 50% higher volume of well-aerated lung tissue
as compared with animals exposed to LPS alone (P = 0.03).
However, when examined at end-inspiration, the difference
was no longer significant, with an average of 66% well-aerated
lung tissue volume in the LPS+inhAPC group compared with
53% with LPS alone (P = 0.06). Correspondingly, when exam-
ined at FRC, the gas/tissue ratio was also higher in the
LPS+inhAPC group as compared with sheep exposed to LPS
alone (Figure 4; P = 0.03), but the intergroup difference was
not present at end inspiration (P = 0.09). Total lung gas and
tissue volumes (data not presented) displayed no significant
intergroup differences at FRC or end inspiration.
PAP, PAOP, Pmo, PVRI and HR all increased significantly with
infusion of LPS and remained elevated throughout the experi-
ment (Table 2). After LPS, CI increased transiently without sig-
nificant differences within or between the groups. MAP tended
to decrease during exposure to LPS (P = 0.06) and SVRI
declined gradually (P = 0.02) in concert with almost a dou-
bling of RAP (P < 0.001). Moreover, LVSWI decreased (P =
0.01) while RVSWI and EVLWI increased slightly during
TVI V V V CT WA PA NA =× () +× () +× () 02 5 07 10 .. .
gas volume index (mL/kg) = lung volume index tissue volume −    index,
and gas/tissue ratio = gas volume index/tissue volu ume index.Critical Care    Vol 13 No 2    Waerhaug et al.
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infusion of LPS (P = 0.006 and 0.02, respectively). However,
inhaled APC had no significant effects on any of the LPS-
induced changes in these haemodynamic and volumetric
variables.
Discussion
The present study is the first in a larger animal model showing
that treatment with inhAPC counteracts LPS-induced ALI by
improving gas exchange, and maintaining well-aerated lung
volumes and lung gas/tissue ratio, as assessed by quantitative
CT.
Our findings confirm the results of investigations showing that
APC possesses the ability to modulate various forms of ALI in
sheep [11,12,16,17]. Employing an ovine model of endotoxin-
induced lung injury, our group noticed that intravenously
infused APC, at the same dose as used for treatment of severe
sepsis, improves oxygenation and reduces the increments in
Pmo and EVLW [11]. However, apart from oxygenation, which
reached criteria of ALI in six animals and ARDS in two animals
of the LPS-group [18] and improved markedly on treatment
with inhaled APC, none of the latter variables changed signifi-
cantly in the present study.
We interpret the decrease in PaCO2 and the parallel rise in pH
following inhalation of APC (Table 1) as indications of
improved alveolar ventilation because the ventilator settings
were kept constant from the beginning to the end of the
experiments.
The improvement of oxygenation in parallel with the demon-
stration of larger volumes of well-aerated lung at FRC indi-
cates that inhaled APC may have prevented the emergence of
densities occurring with LPS alone (Figures 2 and 3). Such
densities are usually seen in patients with ALI [4,19,20]. In
support of these observations, investigators recently reported
a patient with severe sepsis-induced ARDS who presented
with a resolution of the diffuse infiltrates on the chest x-ray in
concert with increased PaO2/FiO2 ratio after four days of treat-
ment with inhaled APC [21].
The fact that the gas/tissue ratio was higher in APC-treated
animals compared with sheep exposed to LPS alone (Figure
4) is most likely a result of more atelectasis in the latter group.
The intergroup difference of well-aerated lung volumes van-
ished at end inspiration probably because the LPS group had
more recruitable lung tissue compared with the group treated
with inhaled APC. In the LPS group, larger parts of the airways
closed during the expiration. Most likely, this closure could be
reduced or prevented by the application of PEEP, as shown in
patients with ARDS [15]. We believe that the LPS+inhAPC
group had more open airways as a result of the treatment.
These findings agree with the observations of reduced peak
airway pressure and bronchial obstruction after APC in an
Figure 1
Changes in oxygenation variables in anaesthetised mechanically venti- lated sheep Changes in oxygenation variables in anaesthetised mechanically venti-
lated sheep. Data presented as the mean ± standard error of the mean. 
Sham = sham-operated group (n = 8); LPS = lipopolysaccharide group 
(n = 8); LPS+inhAPC = LPS group treated with inhaled recombinant 
human activated protein C (n = 8); PaO2 = arterial oxygen partial pres-
sure; AaPO2 = alveolar–arterial oxygen tension difference; Qs/Qt = 
venous admixture. *P < 0.05 between LPS and LPS+inhAPC-groups; 
†P < 0.05 from t = 0 hours in LPS-group; ‡P < 0.05 from t = 0 hours in 
LPS+inhAPC-group.Available online http://ccforum.com/content/13/2/R51
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ovine model of lung injury after smoke inhalation and sepsis
[16].
APC appeared to be less effective in dampening LPS-induced
lung haemodynamic responses when administered directly
into the airways, compared with the intravenous route
[11,16,17]. Concerning PAP, PAOP and Pmo, their
responses to LPS did not differ significantly from the corre-
sponding responses we observed previously [11]. Although
these variables tended to decrease during inhaled APC, we
found no differences compared with those observed with LPS
alone. However, the present investigation was probably under-
powered to unveil these possible effects. Reaching intergroup
differences with 80% power at a probability of 5% would
require sample sizes of 30 animals or more in each group. The
limited effects on pulmonary haemodynamics may be
explained by a lower systemic concentration of the active drug,
which could be caused by limited absorption of APC from the
airways or even a damaging effect of the nebuliser on the APC
molecules.
In the present study, EVLWI increased by only 23% with LPS
alone (P = 0.03). This is a small increase compared with the
more than 100% increments we observed in endotoxaemic
spontaneously breathing sheep studied awake [11,22-24].
Mechanical ventilation reduces the transmural microvascular
pressure, which might explain the decreased lung oedema for-
mation in the present study, but when PEEP is applied this
effect may be partly outweighed by a decrease in lung lymph
flow [25]. Additionally, we suspect that the batch of E. coli
Table 1
Effects of inhaled activated protein C on lipopolysaccharide-induced changes in oxygen related variables and body temperature.
0 hour 2 hours 4 hours 6 hours
SaO2, %
Sham 97 ± 1 98 ± 0 98 ± 1 98 ± 1
LPS 97 ± 1 86 ± 3a 84 ± 3a 84 ± 4a
LPS+inhAPC 98 ± 1 86 ± 3a 93 ± 2ab 94 ± 1ab
SvO2, %
Sham 68 ± 2 69 ± 2 68 ± 2 67 ± 2
LPS 64 ± 2 58 ± 4 51 ± 4a 54 ± 5a
LPS+inhAPC 68 ± 2 58 ± 3a 65 ± 3bc 64 ± 4b
Temp, C°
Sham 38.1 ± 0.3 38.4 ± 0.4 38.8 ± 0.4ab 38.8 ± 0.4ab
LPS 38.3 ± 0.3 39.4 ± 0.3a 40.2 ± 0.2ab 40.4 ± 0.3ab
LPS+inhAPC 38.3 ± 0.1 39.4 ± 0.1a 40.3 ± 0.1ab 40.5 ± 0.1ab
Hb, g/dL
Sham 8 ± 0 9 ± 0 9 ± 0 8 ± 0
LPS 9 ± 1 11 ± 1a 11 ± 1a 11 ± 1a
LPS+inhAPC 9 ± 0 12 ± 0a 12 ± 0a 11 ± 0a
pH
Sham 7.53 ± 0.01 7.54 ± 0.01 7.56 ± 0.01 7.53 ± 0.01
LPS 7.52 ± 0.01 7.51 ± 0.02 7.51 ± 0.02 7.52 ± 0.02
LPS+inhAPC 7.51 ± 0.01 7.48 ± 0.02 7.53 ± 0.02bc 7.54 ± 0.01ab
PaCO2
Sham 37 ± 2 36 ± 2 35 ± 1 34 ± 2
LPS 40 ± 2 41 ± 2 41 ± 2 39 ± 2
LPS+APC 40 ± 1 42 ± 3 37 ± 2b 37 ± 1b
Data presented as the mean ± standard error of the mean.
Hb = haemoglobin; LPS = sheep receiving infusion of lipopolysaccharide (n = 8); LPS+inhAPC = sheep receiving LPS and inhaled nebulised 
recombinant human activated protein C (n = 8); PaCO2 = arterial carbon dioxide partial pressure; pH = arterial pH;. SaO2 = arterial oxygen 
saturation; Sham = sham operated sheep (n = 8); SvO2 = central venous oxygen saturation; Temp = body temperature.
aP < 0.05 from t = 0 hours; bP < 0.05 from t = 2 hours; cP < 0.05 between LPS and LPS+inhAPC-groups.Critical Care    Vol 13 No 2    Waerhaug et al.
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Figure 2
Representative lung computed tomography scans of anaesthetised  mechanically ventilated sheep taken at functional residual capacity Representative lung computed tomography scans of anaesthetised 
mechanically ventilated sheep taken at functional residual capacity. 
Top: sham-operated sheep. Middle: sheep subjected to continuous 
infusion of lipopolysaccharide (LPS). Bottom: sheep subjected to LPS 
and treated with aerosolised inhaled recombinant human activated pro-
tein C.
Figure 3
Volumes of well-aerated, poorly aerated and non-aerated lung deter- mined with quantitative computed tomography at functional residual  capacity and at end inspiration in anaesthetised mechanically ventilated  sheep Volumes of well-aerated, poorly aerated and non-aerated lung deter-
mined with quantitative computed tomography at functional residual 
capacity and at end inspiration in anaesthetised mechanically ventilated 
sheep. Data presented as the mean ± standard error of the mean. FRC 
= functional residual capacity; LPS = lipopolysaccharide group (n = 8); 
LPS+inhAPC = LPS group treated with aerosolised inhaled recom-
binant human activated protein C (n = 8); Sham = sham-operated 
group (n = 8). * P < 0.05 between LPS and LPS+inhAPC groups.
Figure 4
Lung gas/tissue ratio determined with quantitative computed tomogra- phy at functional residual capacity and at end inspiration in anaesthe- tised mechanically ventilated sheep Lung gas/tissue ratio determined with quantitative computed tomogra-
phy at functional residual capacity and at end inspiration in anaesthe-
tised mechanically ventilated sheep. Data presented as the mean ± 
standard error of the mean. FRC = functional residual capacity; LPS = 
lipopolysaccharide group (n = 8); LPS+inhAPC = LPS group treated 
with aerosolised inhaled recombinant human activated protein C (n = 
8); Sham = sham-operated group (n = 8). * P < 0.05 between LPS and 
LPS+inhAPC groups.Available online http://ccforum.com/content/13/2/R51
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Table 2
Effects of inhaled activated protein C on lipopolysaccharide-induced changes in systemic and pulmonary haemodynamic variables 
in sheep.
0 hour 1 hour 2 hours 4 hours 6 hours
PAP, mmHg
Sham 15 ± 1 16 ± 1 16 ± 1 17 ± 1 17 ± 1
LPS 18 ± 0 46 ± 2a 32 ± 2a 35 ± 2a 33 ± 2a
LPS+inhAPC 17 ± 0 47 ± 2a 30 ± 1a 31 ± 1a 29 ± 1a
PAOP, mmHg
Sham 7 ± 1 7 ± 1 8 ± 1 8 ± 1 7 ± 1
LPS 9 ± 1 13 ± 1a 12 ± 1a 14 ± 1ab 14 ± 1ab
LPS+inhAPC 9 ± 1 14 ± 1a 11 ± 1a 13 ± 1a 12 ± 1a
Pmo, mmHg
Sham 6 ± 1 7 ± 1 7 ± 1 7 ± 1
LPS 9 ± 0 13 ± 1a 14 ± 1a 15 ± 1a
LPS+inhAPC 9 ± 1 13 ± 1 12 ± 1a 12 ± 1
PVRI, dyne·sec/cm5/m2
Sham 144 ± 18 151 ± 25 156 ± 35 173 ± 26 191 ± 18
LPS 179 ± 12 665 ± 107a 353 ± 49a 433 ± 64a 339 ± 56a
LPS+inhAPC 165 ± 16 563 ± 63a 351 ± 31a 379 ± 37a 350 ± 33a
HR, beats/min
Sham 102 ± 6 111 ± 6 111 ± 6 107 ± 7 100 ± 8
LPS 100 ± 9 142 ± 15a 154 ± 11a 131 ± 10ab 140 ± 5a
LPS+inhAPC 93 ± 10 160 ± 16a 160 ± 15a 121 ± 4ab 128 ± 6ab
CI, L/min/m2
Sham 4.5 ± 0.4 4.6 ± 0.4 4.1 ± 0.2 4.2 ± 0.3 4.3 ± 0.3
LPS 4.0 ± 0.3 5.0 ± 0.9 4.8 ± 0.3 4.6 ± 0.6 4.6 ± 0.4
LPS+inhAPC 4.2 ± 0.3 5.3 ± 0.7 4.7 ± 0.3 4.1 ± 0.2 4.2 ± 0.4
MAP, mmHg
Sham 112 ± 5 118 ± 6 118 ± 6 116 ± 5 112 ± 6
LPS 108 ± 6 102 ± 6 96 ± 6 103 ± 6 93 ± 5
LPS+inhAPC 110 ± 6 110 ± 4 102 ± 5 111 ± 8 108 ± 9
SVRI, dyne·sec/cm5/m2
Sham 2068 ± 230 2146 ± 234 2261 ± 179 2251 ± 207 2139 ± 226
LPS 2159 ± 179 2003 ± 466 1577 ± 146 1824 ± 243 1499 ± 154a
LPS+inhAPC 2151 ± 174 1849 ± 245 1839 ± 179 2188 ± 249 2130 ± 290
RAP, mmHg
Sham 2 ± 1 3 ± 1 3 ± 1 3 ± 1 3 ± 1
LPS 5 ± 1 5 ± 1 5 ± 1 9 ± 1ab 10 ± 1ab
LPS+inhAPC 3 ± 0 3 ± 1 3 ± 1 6 ± 1ab 8 ± 1ab
LVSWI, g·m/m2
Sham 63 ± 4 72 ± 9 56 ± 4 58 ± 6 60 ± 6Critical Care    Vol 13 No 2    Waerhaug et al.
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LPS, which we used in this and a concurrent investigation
[13], was less potent than that employed in previous experi-
ments concerning the induction of lung oedema.
The modest lung oedema could not account for the significant
hypoxaemia noticed in this study. The derangement of oxygen-
ation, most likely, resulted from the emerging atelectasis. In
atelectatic and poorly ventilated areas of lungs, the pulmonary
vasoconstrictor response to hypoxia (HPV) normally acts to
redistribute blood flow to better ventilated areas [26]. It is well
established that infusion of LPS, or sepsis, hampers HPV by
inducing endogenous production of the vasodilator nitric oxide
[27,28]. In sepsis, HPV recovers after inhibition of inducible
nitric oxide synthase [28]. Sheep subjected to combined
smoke inhalation and sepsis, presented with reduced levels of
lung tissue of the nitric oxide metabolite tri-nitrotyrosine after
intravenously administered APC [16]. APC also prevented
endotoxin-induced hypotension in rats by inhibiting excessive
nitric oxide production [29]. Thus, we speculate that preserva-
tion of HPV, at least in part, can explain the improvement of
oxygenation in animals treated with inhaled APC.
We suggest that the present attenuation of ALI is caused by
anticoagulant, anti-inflammatory and profibrinolytic effects of
APC, as we have demonstrated previously in endotoxaemic
sheep [11]. Consistent with our previous observations, we did
not notice any signs of bleeding from the airways, or from any
other organ system after inhaled APC. The possibility of any
hidden bleeding into the lung interstitium after exposure to
inhaled APC is also less likely because such an event would
worsen rather than improve oxygenation and the gas/tissue
ratio.
The present study has limitations. We did not assess the dis-
tribution of inhaled APC within the lungs or its final plasma
concentration, thus necessitating further studies. However,
visual inspection revealed that a vapour containing the aero-
solised solution of APC entered the endotracheal tube during
inspiration. Taking into account a molecular weight of more
than 50 kD, we assume that the size of the aerosolised parti-
cles might have limited their access to the smallest airways.
Nevertheless, the clinical effects, particularly on oxygenation
and lung aeration, make us believe that some of the active drug
reached the distal airways. However, the fact that we observed
no significant effects on LPS-induced changes in pulmonary
haemodynamics, indicate that systemic absorption was
sparse. Although the present findings cannot be immediately
extrapolated to humans, they suggest a role for inhAPC, par-
ticularly in patients with sepsis-induced ALI at increased risk of
bleeding. We recommend that inhaled APC should be sub-
jected to a clinical trial in patients with ALI or ARDS after
sepsis.
Conclusions
The present study demonstrates that treatment of ovine endo-
toxin-induced lung injury with aerosolised inhaled recombinant
human APC improves oxygenation, and maintains aeration of
lung tissue, as assessed by CT.
LPS 52 ± 7 42 ± 6 36 ± 5a 39 ± 3 33 ± 3a
LPS+inhAPC 66 ± 6 42 ± 4 36 ± 4a 43 ± 3a 41 ± 4a
RVSWI, g·m/m2
Sham 7 ± 1 9 ± 2 6 ± 1 8 ± 1 8 ± 2
LPS 7 ± 1 19 ± 3a 11 ± 1a 11 ± 1a 9 ± 1a
LPS+inhAPC 9 ± 1 19 ± 2 11 ± 1 12 ± 1 10 ± 1
EVLWI, mL/kg
Sham 10 ± 1 10 ± 0 10 ± 0 10 ± 0
LPS 10 ± 1 11 ± 1 11 ± 0 12 ± 1a
LPS+inhAPC 9 ± 0 11 ± 1a 10 ± 1 11 ± 1a
Data presented as the mean ± standard error of the mean.
CI = cardiac index; EVLWI = extravascular lung water index; HR = heart rate; LPS = sheep receiving infusion of lipopolysaccharide (n = 8); 
LPS+inhAPC = sheep receiving LPS and inhaled nebulised recombinant human activated protein C (n = 8); LVSWI = left ventricle stroke work 
index; MAP = mean systemic arterial pressure; PAP = pulmonary artery pressure; PAOP = pulmonary artery occlusion pressure; Pmo = 
pulmonary micro occlusion pres#monary vascular resistance index; RAP = right atrial pressure; RVSWI = right ventricle stroke work index;Sham 
= sham operated sheep (n = 8); SVRI = systemic vascular resistance index.
aP < 0.05 from t = 0 hours; bP < 0.05 from t = 2 hours.
Table 2 (Continued)
Effects of inhaled activated protein C on lipopolysaccharide-induced changes in systemic and pulmonary haemodynamic variables 
in sheep.
Key messages
￿  In anaesthetised mechanically ventilated sheep, treat-
ment with aerosolised inhaled recombinant human APC 
counteracts the decline in well-aerated lung volumes 
and the deterioration of oxygenation after endotoxin-
induced lung injury.Available online http://ccforum.com/content/13/2/R51
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